A possible tumour-suppressor role for HOXA5 is also supported by low HOXA5 expression in breast [7] and lung cancer [34] tissues which is thought to be mediated by methylation of the CpG island located on the 5' end of the HOXA5 gene [7]. This evidence concerns the gene HOXA5 and lung carcinoma.